Status:

COMPLETED

Bioavailability of Two Sustained-release Theophylline Products in Healthy Males

Lead Sponsor:

Boehringer Ingelheim

Conditions:

Healthy

Eligibility:

MALE

18-45 years

Phase:

PHASE1

Brief Summary

Study to compare the bioavailability of 350 mg Bronchoretard® - a sustained-release theophylline (anhydrous) product with respect to the reference product, Theo Dur® 300 mg theophylline anhydrous (sus...

Eligibility Criteria

Inclusion

  • Healthy, non-smoking male subjects between 18 and 45 years of age
  • Body weight within 10% of the ideal weight according to the Body Mass Index (BMI)
  • Normal health based on medical history and findings within the range of clinical acceptability, in respect of the physical examination (including electrocardiogram and vital signs) and special investigations
  • Ability to comprehend and willingness to sign both statements of informed consent (for screening and study-specific procedures)

Exclusion

  • History of serious systemic or organ disease
  • A major illness during the 3 months before commencement of the study-related procedures
  • Significant physical or organ abnormality
  • History of hypersensitivity to theophylline or other xanthine derivatives
  • Use of any medication within 2 weeks before the first administration of study medication
  • Participation in another study with an experimental drug within 8 weeks before the first administration of study medication
  • Treatment within the previous 3 months with any drug with a well-defined potential for adversely affecting a major organ or system (for example chloramphenicol, which may cause bone marrow suppression)
  • Donation of blood during the 8 weeks before the first administration of study medication
  • History of, or current compulsive alcohol abuse (\> 10 drinks per week), of regular exposure to other substance of abuse
  • Positive testing for HIV and hepatitis B antigens within the previous 3 months

Key Trial Info

Start Date :

April 1 1998

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

Estimated Enrollment :

22 Patients enrolled

Trial Details

Trial ID

NCT02184247

Start Date

April 1 1998

Last Update

July 9 2014

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.